Fate of Merck’s vorapaxar still unclear
February 8, 2012Medical Communications, Sales and Marketing Merck, vorapaxar
Merck & Co’s blood thinner vorapaxar, designed to prevent blood clots and reduce heart attacks, is still causing bleeding in …
New drug discounts should be made transparent
February 8, 2012Medical Communications, Sales and Marketing ABPI, NHS, NICE, access scheme, pricing
Patient access schemes agreed through NICE should be made more transparent. This is according to Paul McManus, a pharmacist and …
GSK posts strong underlying sales growth
February 8, 2012Research and Development, Sales and Marketing Avodart, GSK, R&D, Seretide, Witty, rotarix
GlaxoSmithKline has posted strong underlying growth for 2011, but warns of a tough year ahead. The UK firm saw 4% …
Hospira appoints Richard Davies as chief commercial officer
February 8, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hospira, Richard Davies
Hospira has announced Richard Davies as its senior vice president and chief commercial officer. In this role, he will be responsible for …
Breast cancer treatment – the next advances
February 7, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Afinitor, CDF, Lorena Tonarelli, T-DM1, breast cancer, pertuzumab
When a close member of my family was diagnosed with breast cancer, the doctors didn’t give us much hope. They …
Merck prepares insomnia candidate
February 7, 2012Sales and Marketing Merck, insomnia
Merck is to file its new insomnia drug suvorexant, with US regulators later this year. Suvorexant is an orexin receptor …
Dr Stephen Rosevear joins Cogent as director of Research & Policy
February 7, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cogent, Stephen Rosevear
Prior to joining Cogent, Stephen was HMRC’s chief analyst on the corporate real estate market, undertaking tax modeling and policy development for …
Roche rounds off year with solid performance
February 3, 2012Sales and Marketing Roche
A strong performance in its diagnostics division was among the factors enabling Roche to deliver a solid set of results …
Andrew Morgan joins Republic M!
February 2, 2012Business Services, Medical Communications, Sales and Marketing Andrew Morgan, Republic M!
Republic M! has strengthened its team with the appointment of Andrew Morgan as head of operations. Andrew has leadership expertise …
Merck posts strong results for 2011
February 2, 2012Sales and Marketing Frazier, Merck, Singulair, Victrelis
Foreign exchange rates and strong sales from established products helped Merck to achieve single-digit growth for 2011. The US firm …
Working Life: Carlos Gallardo, general manager, Almirall
February 2, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Almirall, Carlos Gallardo
BiographyCarlos Gallardo is general manager of the Almirall UK and Ireland affiliate from its creation in 2008. He has an …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
